SiSaf Announces Michael J. Econs MD, World-leading Expert in Metabolic Bone Disease, as Clinical Advisor

/PRNewswire/ -- SiSaf Ltd, a company developing RNA therapeutics for rare genetic skeletal disorders, today announced that it has appointed Professor Michael J....

Related Keywords

Guildford ,Surrey ,United Kingdom ,Sisaf Bio ,Suzanne Saffie Siebert ,Sue Charles ,Scius Communications ,Linkedin ,Prnewswire Sisaf Ltd ,Twitter ,Vickers Venture Partners United Kingdom Future Fund ,Saf Ltd ,Professor Michael ,Molecular Genetics ,Indiana University School ,Professor Econs ,Clinical Advisor ,Principal Investigator ,Orphan Drug Designation ,Vickers Venture Partners ,United Kingdom Future ,Sisaf ,